These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The influence of some drugs on platelet aggregation and adhesion. Bielawiec M; Perzanowski A; Myśliwiec M Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729 [No Abstract] [Full Text] [Related]
5. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma]. Rudobielski R Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093 [No Abstract] [Full Text] [Related]
6. [Differential diagnosis of arteriosclerosis obliterans and thromboangiitis obliterans]. Emmrich R Z Gesamte Inn Med; 1973 Jul; 28(13):389-94. PubMed ID: 4804902 [No Abstract] [Full Text] [Related]
7. [Characteristics of metabolism in patients with arteriosclerosis obliterans and arteritis]. Savel'ev VS; Koshkin VM; Chesnokova TT; Endlina OV; Baranov AP Kardiologiia; 1988 Sep; 28(9):35-8. PubMed ID: 3236641 [TBL] [Abstract][Full Text] [Related]
8. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids. Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405 [TBL] [Abstract][Full Text] [Related]
9. Some hematologic differences between thromboangiitis obliterans and atherosclerosis. Craven JL; Cotton RC Angiology; 1968 Sep; 19(8):450-9. PubMed ID: 5677577 [No Abstract] [Full Text] [Related]
10. [A method of correction of hemorheological disorders in patients with thrombobliterating diseases of the peripheral arteries of the limbs]. Litmanovich KIu; Mel'nikova VN; Fregatova LM; Kargin VD; Egorova LV Vestn Khir Im I I Grek; 1985 Jul; 135(7):96-9. PubMed ID: 4060495 [TBL] [Abstract][Full Text] [Related]
11. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs]. Berent H; Kancelarczyk WL; Zebrowski M; Uchman B Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518 [No Abstract] [Full Text] [Related]
12. [Determination of blood glucosamine level in certain vascular disease]. SAWICKI A Pol Arch Med Wewn; 1958; 28(5):705-6. PubMed ID: 13601311 [No Abstract] [Full Text] [Related]
13. [On activation of fibrinolysis in vitro and in vivo by nicotinic acid, heparin and their mixtures]. Goossens N Med Welt; 1967 Apr; 14():899-903. PubMed ID: 4869469 [No Abstract] [Full Text] [Related]
14. [Serum N-acetylneuraminic acid in patients with chronic ischemia of the extremities]. Walaszewska B Pol Arch Med Wewn; 1969; 42(1):83-7. PubMed ID: 5767515 [No Abstract] [Full Text] [Related]
15. [Variability of blood lipoprotein spectrum after injections of small doses of heparin]. SZAJEWSKI J Pol Arch Med Wewn; 1958; 28(5):702-5. PubMed ID: 13601310 [No Abstract] [Full Text] [Related]
16. Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. Musiał J; Wilczyńska M; Sładek K; Cierniewski CS; Nizankowski R; Szczeklik A Prostaglandins; 1986 Jan; 31(1):61-70. PubMed ID: 2419945 [TBL] [Abstract][Full Text] [Related]
17. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid]. Kiseleva LN; Romanenko GK Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141 [No Abstract] [Full Text] [Related]
18. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate]. Blasi A; Licciardello M Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024 [No Abstract] [Full Text] [Related]
19. [Nicotinic acid level in the blood and fibrinolysis under the influence of hexanicotinic acid esters of m-inositol]. Sommer H Arzneimittelforschung; 1965 Nov; 15(11):1337-9. PubMed ID: 5340070 [No Abstract] [Full Text] [Related]
20. [Variations in fibrinolytic activity and fibrinogen caused by xanthinol nicotinate in cases of diabetes mellitus with peripheral vascular lesions]. Ipbüker A; Bayer H Turk Tip Cemiy Mecm; 1969 Apr; 35(4):236-46. PubMed ID: 5810400 [No Abstract] [Full Text] [Related] [Next] [New Search]